1q21 Gain Combined with High‐Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China

BACKGROUND. The prognostic value of 1q21 gain in newly diagnosed multiple myeloma (NDMM) remains controversial. Our aim was to investigate the prognostic value of 1q21 gain in a Chinese population. MATERIALS AND METHODS. We retrospectively identified 565 patients with NDMM from multiple centers in C...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncologist
Main Authors: Li, Xiaozhe, Chen, Wenming, Wu, Yin, Li, Jianyong, Chen, Lijuan, Fang, Baijun, Feng, Ying, Liu, Junru, Chen, Meilan, Gu, Jingli, Huang, Beihui, Li, Juan
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Inc. 2019
Fag:
Hematologic Malignancies
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6853115/
https://ncbi.nlm.nih.gov/pubmed/31455749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0132
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker